http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3b578eb227c0e1848e9f31790fa2d28
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Schulte |
| name | Johannes H. Schulte Johannes H Schulte |
| given-name | Johannes H Johannes H. |
| organization-name | Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany; Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany; Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany Department of Pediatrics, Division of Oncology and Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany; Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany Authors' Affiliations: 1Center for Medical Genetics, Ghent University, Ghent University Hospital, Ghent, Belgium; Departments of 2Theoretical Bioinformatics and 3Tumour Genetics, German Cancer Research Center, Heidelberg, Germany; 4Institut National de la Sante et de la Recherche Medicale U830, Institut Curie, Paris, France; 5Division of Hematology and Oncology, University Children's Hospital Essen, Essen, Germany; 6Children's Hospital of Cologne, Department of Pediatric Oncology, Cologne, Germany; 7Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Barcelona, Spain; 8Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and 9Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba, Japan Department of Pediatric Oncology and Hematology, University Children’s Hospital Essen, 45122 Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, 45122 Essen, Germany.; Department of Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Hufelandstr.55, 45122 Essen, Germany.; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Centre for Medical Biotechnology, University Duisburg-Essen, 45122 Essen, Germany. Department of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Berlin, Germany Department of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Charité—Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany; Berlin Institute of Health, Berlin, Germany Department of Pediatric Oncology and Haematology; University Children's Hospital Essen; Essen Germany Department of Pediatric Hematology and Oncology, Charité University Medicine Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany. Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. Department of Pediatric Oncology and Hematology, Charite University Hospital, Berlin, Germany Authors' Affiliation: Division of Hematology and Oncology, University Children's Hospital Essen, Essen, Germany Department of Pediatric Hematology-Oncology, Pediatrics III; University Duisburg-Essen; Essen Germany Department of Pediatric Oncology and Hematology University Children's Hospital Essen Hufelandstr. 55 45147 Essen Germany; German Cancer Consortium (DKTK) Heidelberg Germany; German Cancer Research Center (DKFZ) D‐69120 Heidelberg Germany; Translational Neuro‐Oncology, West German Cancer Center, University Hospital Essen, University Duisburg‐Essen D‐45122 Essen Germany; Center for Medical Biotechnology (ZMB), University Duisburg‐Essen D‐45122 Essen Germany 2Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Germany.; 11German Cancer Consortium (DKTK), Germany.; 12Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; 13German Cancer Research Center (DKFZ), Heidelberg, Germany.; 14Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany. 2Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany.; 3German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Duesseldorf, Essen, Germany.; 6Neuroblastoma Genomics, B087, German Cancer Research Center (DKFZ), Heidelberg, Germany.; 13Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.; 14Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany. Department of Pediatric Oncology and Hematology, University Children’s Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany. Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany 1Department of Paediatric Oncology and Hematology, University Children's Hospital Essen; Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Germany; Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany Department of Pediatric Hematology, Oncology and SCT, Charité - University Hospital Berlin, Campus Virchow-Klinikum, Berlin, Germany Department of Pediatric Hematology and Oncology Kinderklinik III, Universitätsklinikum‐Essen and the University of Duisburg‐Essen Essen Germany; Charité Universitätsmedizin, Department of Pediatrics Division of Oncology and Hematology Berlin Germany; German Consortium for Translational Cancer Research (DKTK) Heidelberg Germany; Translational Neuro‐Oncology, West German Cancer Center (WTZ) University Hospital Essen Essen Germany Department of Pediatric Oncology/Hematology, Charité- Universitätsmedizin Berlin, Germany; German Consortium for Translational Cancer Research (DKTK), Partner Site Charite Berlin, Berlin, Germany Authors' Affiliations: 1Department of Pediatric Oncology and Hematology, University Children's Hospital; 2Institute of Pharmacogenetics, University Hospital, Essen, Germany; 3Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium; 4Department of Pediatric Oncology and Hematology, University Children's Hospital, and Center for Molecular Medicine Cologne (CMMC), Cologne; 5Department of Tumor Genetics (B030), German Cancer Research Center; and 6Department of Theoretical Bioinformatics (B080), German Cancer Research Center, Heidelberg, Germany Authors' Affiliations: 1Department of Cancer Genetics, Royal College of Surgeons in Ireland; 2Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland; 3University Children's Hospital, Essen, Germany; and 4Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium Department of Pediatric Hematology and Oncology Charité ‐ Universitätsmedizin Berlin Berlin Germany; Berliner Institut für Gesundheitsforschung (BIH) Berlin Germany; German Cancer Consortium (DKTK) Berlin Germany; German Cancer Research Center (DKFZ) Heidelberg Germany Department of Pediatric Hematology and Oncology Charité—Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin Germany; Berliner Institut für Gesundheitsforschung (BIH), Anna‐Louisa‐Karsch‐Straβe 2, 10178 Berlin Germany; German Cancer Consortium (DKTK), Partner Site Berlin Berlin Germany; German Cancer Research Center (DKFZ) Heidelberg Germany Department of Pediatric Oncology and Hematology University Hospital Essen Germany; Centre for Medical Biotechnology, University Duisburg‐Essen Essen Germany Department of Pediatric Oncology and Hematology Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt ‐ Universität zu Berlin, and Berlin Institute of Health Berlin Germany; German Cancer Consortium (DKTK) Heidelberg Germany; German Cancer Research Center (DKFZ) Heidelberg Germany Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, HufelandstraΔe, Essen, Germany Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany; Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany 9Department of Pediatric Oncology, Hematology and BMT, Charité University Medicine, Berlin, Germany.; 10German Cancer Consortium (DKTK), Berlin, Germany.; 11German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Pediatric Oncology and Hematology University Children's Hospital Essen Essen Germany; German Cancer Consortium (DKTK) Germany; German Cancer Research Center (DKFZ) Heidelberg Germany; Translational Neuro‐Oncology, West German Cancer Center University Hospital Essen, University Duisburg‐Essen Essen Germany; Center for Medical Biotechnology University Duisburg‐Essen Essen Germany Department of Pediatric Oncology and Hematology Charité University Medicine Berlin Berlin Germany Department of Pediatric Hematology and Oncology Charité ‐ Universitätsmedizin Berlin Berlin Germany; German Cancer Consortium (DKTK) Berlin Germany; German Cancer Research Center (DKFZ) Heidelberg Germany; Berliner Institut für Gesundheitsforschung (BIH) Berlin Germany Department of Pediatric Oncology and Hematology, University Children’s Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany.; Department of Pediatric Oncology and Hematology, Charité Berlin, Charitéplatz 1, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), 13353 Berlin, Germany. Authors' Affiliations: 1Center for Medical Genetics, 2Department of Paediatric Haematology and Oncology, and 3Department of Pathology, Ghent University Hospital, Ghent, Belgium; 4Department of Molecular and Developmental Genetics, K.U.Leuven-VIB, and 5Department of Paediatrics, University Hospital Leuven, Leuven, Belgium; 6Department of Human Genetics, Academic Medical Center, University of Amsterdam, and 7Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands; 8Division of Hematology and Oncology, University Children's Hospital Essen, Essen, Germany; 9Department of Pathology, Rikshospitalet, Oslo, Norway; 10Department of Pathology, Medical School of Valencia, University of Valencia, Valencia, Spain; 11INSERM U830, Institut Curie, Paris, France; 12Childhood Cancer Research Unit, Karolinska Institutet, Astrid Lindgren Children's Hospital, Stockholm, Sweden; 13Department of Clinical Genetics, Gothenburg University, Gothenburg, Sweden; 14Division of Bioch Department of Pediatric Oncology/Hematology/Stem Cell Transplantation Charité‐Universitätsmedizin Berlin Berlin Germany Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany; Berlin Institute of Health (BIH), Germany; German Cancer Consortium (DKTK Berlin), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany Authors' Affiliations: 1Center for Medical Genetics; 2Department of Paediatric Hematology and Oncology, Ghent University Hospital, Ghent, Belgium; 3Children's Oncology Group, University of Florida, Gainesville, Florida; 4Department of Cancer Genetics, Royal College of Surgeons in Ireland, and National Children's Research Centre, Dublin, Ireland; 5Pediatric Oncology Unit, Hospital La Fe, Valencia; 6Department of Pathology, Medical School, University of Valencia, Valencia, Spain; 7Applied Biosystems, Foster City, California; 8Department of Pediatric Haematology, Oncology and Endocrinology, Medical University of Gdansk, Gdansk, Poland; 9Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Essen, Germany; 10Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; 11Children's Oncology Group, Children's Hospital Boston/Dana-Farber Harvard Cancer Center, Boston, Massachusetts; 12Department of Computer Science, Technische Universität Dortmund, Dor Berlin Institute of Health, 10178 Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), 10117 Berlin, Germany.; Deutsches Krebsforschungszentrum Heidelberg, 69120 Heidelberg, Germany. Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany Authors' Affiliations: 1Children's Hospital, Department of Pediatric Oncology and Hematology and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 2Department of Pediatric Oncology and Hematology, University Hospital of Essen, Essen, Germany; 3University of Heidelberg, Institute of Pathology (INF 220), Heidelberg, Germany Department of Pediatric Oncology and Hematology Charité – Universitätsmedizin Berlin Berlin Germany; German Cancer Consortium (DKTK) Berlin Germany; German Cancer Research Center (DKFZ) Heidelberg Germany Department of Pediatric Oncology, Hematology and SCT, Charité, 13353 Berlin, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany German Cancer Consortium, D-69120 Heidelberg, Germany;; Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, D-45122 Essen, Germany;; DKFZ, D-69120 Heidelberg, Germany;; Department of Pediatric Oncology and Hematology, University Children’s Hospital Essen, D-45122 Essen, Germany;; Centre for Medical Biotechnology, University Duisburg-Essen, D-45122 Essen, Germany; 4Department of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.; 5German Cancer Consortium (DKTK Berlin), Berlin, Germany.; 6Berlin Institute of Health (BIH), Berlin, Germany. Jessica L. Bell, Raseswari Turlapati, and Stefan Hüttelmaier, Martin Luther University Halle-Wittenberg, Halle; Johannes H. Schulte, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, and University Children's Hospital Essen, Essen; Johannes H. Schulte, German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; and Tao Liu, Children's Cancer Institute Australia for Medical Research and University of New South Wales, Randwick, New South Wales, Australia. Department of Pediatric Oncology and Hematology University Children's Hospital Essen Essen Germany; Centre for Medical Biotechnology University Duisburg‐Essen Essen Germany |
Incoming Links
Total number of triples: 195.